FDA cleared and clinically validated app allows Venu 2 Plus customers to record an ECG and check for signs of atrial fibrillation directly from their smartwatch
OLATHE, Kan., Jan. 24, 2023 /PRNewswire/ — Garmin (NYSE: GRMN) today announced the EKG application1, an FDA-cleared app for the Venu® 2 Plus smartwatch that allows users to record their heart rhythm and check for signs of Atrial Fibrillation (AFib) anytime, anywhere. Customers can use the ECG app to record a 30-second ECG and view heart rhythm results immediately on the watch or optionally later in the Garmin Connect smartphone app.
“The ECG app is Garmin’s first FDA-cleared smartwatch feature, and we’re excited to offer this revolutionary tool to our customers as another way to stay on top of their health,” said Dan Bartel, vice president of global sales for Garmin. Garmin consumers. “During the early stages of atrial fibrillation, it is common for symptoms to be infrequent, making detection difficult in a clinical setting. With the new ECG app, Venu 2 Plus customers can conveniently take an ECG recording at any time, and optionally , create a report of your results to share with your doctor later.”
When customers take an ECG, the ECG app uses the sensors on the Venu 2 Plus to record the electrical signals that control their heart rate. The ECG app then analyzes the recording for signs of atrial fibrillation. Additionally, users have the ability to sync ECG app results with Garmin Connect. Through the Garmin Connect app, customers can view history of ECG app results and create reports that can be shared with a healthcare professional.
The ECG app is now available on the Venu 2 Plus for customers in the United States and requires the latest version of the Garmin Connect app before use. Garmin plans to continue expanding its portfolio of products that support the ECG app and launch it in new regions in line with the necessary regulatory approval. For more information about the ECG app and how to set it up, visit Garmin.com/ECG.
Designed inside for life outside, Garmin products have revolutionized the wellness industry. Committed to developing wearable devices and health measurement tools that help people of all activity levels lead healthier lives, Garmin believes that every day is an opportunity to innovate and an opportunity to beat yesterday. For more information, visit Garmin’s virtual newsroom, email our press team, connect with @garminwellness on social media, or follow our adventures at garmin.com/blog.
1 The ECG app is available on the Venu 2 Plus smartwatch (firmware version 11.21) with the Garmin Connect smartphone app (version 4.62). The ECG app is not available in all regions; see Garmin.com/ECG for availability. The ECG app is not intended for use by persons under the age of 22. With the ECG app, the Venu 2 Plus smartwatch can generate an ECG similar to a single-lead electrocardiogram.
About Garmin International, Inc. Garmin International, Inc. is a subsidiary of Garmin Ltd. (NYSE: GRMN). Garmin Ltd. is incorporated in Switzerland and has principal subsidiaries in the United States, Taiwan and the United Kingdom. Garmin and Venu are registered trademarks and Garmin Connect is a trademark of Garmin Ltd. or its affiliates. All other brands, product names, company names, trademarks and service marks are the property of their respective owners. All rights reserved.
Notice About Forward-Looking Statements:This release includes forward-looking statements regarding Garmin Ltd. and its business. Such statements are based on management’s current expectations. The forward-looking events and circumstances discussed in this release may not occur and actual results could differ materially as a result of known and unknown risk factors and uncertainties affecting Garmin, including, but not limited to, the risk factors listed in the Report on Form 10-K for the year ended December 25, 2021, filed by Garmin with the Securities and Exchange Commission (Commission file number 0001-411180). A copy of that form 10-K can be found at No forward-looking statements can be guaranteed. Forward-looking statements speak only as of the date they are made, and Garmin undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
Stephanie Schultz913-397-8200[email protected]
SOURCE Garmin International, Inc.
